Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin

Cytokine

Volumn 59, Issue 1, 2012, Pages 131-137

  Sun, Bin ^a   Yang, Gangyi ^a   Yang, Mengliu ^a   Liu, Hua ^b   Boden, Guenther ^c   Li, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FGF 21; High fat diet; Insulin resistance; Visfatin

Indexed keywords

ADIPOCYTOKINE; APOLIPOPROTEIN E; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCOSE; INSULIN; KLOTHO PROTEIN; LIPID; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN BETA KLOTHO; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; DISORDERS OF LIPID METABOLISM; DOWN REGULATION; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEINS E; BLOOD GLUCOSE; DIET, HIGH-FAT; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MICE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; TIME FACTORS;

ANIMALIA; MUS;

EID: 84861685354     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.030     Document Type: Article

References (27)

1. Bloomgarden Z.T. Adiposity and diabetes. Diabetes Care 2002, 25:2342-2349.
2. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
3. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med 2005, 5:333-339.
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
5. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hyper-cholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
6. Plump A.S., Smith J.D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
7. Boord J.B., Maeda K., Makowski L., Babaev V.R., Fazio S., Linton M.F., et al. Adipocyte fatty acid - binding protein, ap2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002, 22:1686-1691.
8. Gable D., Sanderson S.C., Humphrise S.E. Genotypes, obesity and type 2 diabetes-can genetic information motivate weight loss? A review. Clin Chem Lab Med 2007, 45:301-308.
9. Bloomgarden Z.T. Insulin resistance, dyslipidemia, and cardiovascular disease. Diabetes Care 2007, 30:2164-2170.
10. Bloomgarden Z.T. Insulin resistance concepts. Diabetes Care 2007, 30:1320-1326.
11. Li L., Yang G., Shi S., Yang M., Liu H., Boden G. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009, 45:12-19.
12. Kurosu H., Choi M., Ogawa Y., Dickson A.S., Goetz R., Eliseenkova A.V., et al. Tissue-specific expression of betaKlotho and fibroblast growth factor receptor isoforms determines metabolic activity of FGF-19 and FGF-21. J Biol Chem 2007, 282:26687-26695.
13. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005, 115:1627-1635.
14. Kharitonenkov A., Wroblewski V.J., Koester A., Chen Y.F., Clutinger C.K., Tigno X.T., et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007, 148:774-781.
15. Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
16. Xu J., Lloyd D.J., Hale C., Stanislaus S., Chen M., Sivits G., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58:250-259.
17. Berglund E.D., Li C.Y., Bina H.A., Lynes S.E., Michael M.D., Shanafelt A.B., et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009, 150:4084-4093.
18. Hansmann G., Wagner R.A., Schellong S., De Jesus Perez V.A., Urashima T., Wang L., et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 2007, 115:1275-1284.
19. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
20. Qin S., Ling L., Renzhe L., Mengliu Y., Hua L., Michael J., et al. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats. Ann Med 2009, 41:311-320.
21. Saddi-Rosa1 P., Oliveira1 C.S.V., Giuffrida F.M.A., Reis A.F. Visfatin glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syn 2010, 2:21-27.
22. Chen M.P., Chung F.M., Chang D.M., Tsai J.C., Huang H.F., Shin S.J., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91:295-299.
23. Ling L., Gangyi Y., Yi T., Mei Y., Hao Y., Ke L. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006, 114:544-548.
24. Arner P. Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91:28-30.
25. Revollo J.R., Grimm A.A., Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007, 23:164-170.
26. Sethi J.K. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?. Curr Hypertens Rep 2007, 9:33-38.
27. Stephens J.M., Vidal-Puig A.J. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 2006, 17:128-131.